Characterization of Domain V Mutations in Clinical Isolates of Helicobacter pylori in Pakistan and Their Effect on Clarithromycin MIC

References

• NgHK, GohKL, ChuahKH, et al. Sequencing-based detection of 23S rRNA domain V mutations in treatment-naïve Helicobacter pylori patients from Malaysia. J Glob Antimicrob Resist. 2020;23:345–348. doi:10.1016/j.jgar.2020.10.012.Epub 2020 Nov 133137535
   PubMed Web of Science ®Google Scholar
• AlbashaAM, ElnoshMM, OsmanEH, et al. Helicobacter pylori 23S rRNA gene A2142G, A2143G, T2182C, and C2195T mutations associated with clarithromycin resistance detected in Sudanese patients. BMC Microbiol. 2021;21:1–6.33386072
   PubMed Web of Science ®Google Scholar
• MarquesAT, VitorJMB, SantosA, et al. Trends in H. pylori resistance to clarithromycin: from phenotypic to genomic approaches. Microbial Genomics. 2020 Mar;6(3):e000344.doi:10.1099/mgen.0.000344
   Web of Science ®Google Scholar
• VazirzadehJ, FalahiJ, MoghimS, et al. Molecular assessment of resistance to clarithromycin in Helicobacter pylori strains isolated from patients with dyspepsia by fluorescent in situ hybridization in the center of Iran. Biomed Res Int. 2020 Mar 27;2020:2304173.. doi:10.1155/2020/2304173.eCollection2020.
   Web of Science ®Google Scholar
• KocazeybekB, SakliMK, YukselP, et al. Comparison of new and classical point mutations associated with clarithromycin resistance in H. pylori strains isolated from dyspeptic patients and their effects on phenotypic clarithromycin resistance. J Med Microbiol. 2019;68(4):566–573. doi:10.1099/jmm.0.00094430724729
   PubMed Web of Science ®Google Scholar
• Clinical and laboratory Standards Institute (CLSI). Methods for Antimicrobial Dilutions and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria. 3rd ed. CLSI guideline M45. Wayne, PA: Clinical and Laboratory Standards Institute; 2016.
   Google Scholar
• MattarR, LaudannaAA. Helicobacter pylori genotyping from positive CLOtest in patients with duodenal ulcer. Rev Hosp Clin. 2000;55(5):155–160. doi:10.1590/S0041-87812000000500001
   Google Scholar
• VersalovicJ, ShortridgeD, KiblerK, et al. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. J Antimicrob Chemother. 1996;40:477–480. doi:10.1128/AAC.40.2.477
   Web of Science ®Google Scholar
• ChisholmSA, OwenRJ, TeareEL, et al. PCR-based diagnosis of Helicobacter pylori infection and real-time determination of clarithromycin resistance directly from human gastric biopsy samples. J Clin Microbiol. 2001;39:1217–1220. doi:10.1128/JCM.39.4.1217-1220.200111283030
   PubMed Web of Science ®Google Scholar
• SambrookJ, FritschEF, ManiatisT. Molecular Cloning: A Laboratory Manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press; 1989.
   Google Scholar
• AthertonJC, CaoP, PeekRM, et al. Mosaicism in vacuolating cytotoxin alleles of H. pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem. 1999;270:17771–17777. doi:10.1074/jbc.270.30.17771
   Web of Science ®Google Scholar
• PenaAJ, FoxJG, FerraroMJ, et al. Molecular resistance testing of Helicobacter pylori in gastric biopsies. Arch Pathol Lab Med. 2001;125:493–497. doi:10.5858/2001-125-0493-MRTOHP11260622
   PubMed Web of Science ®Google Scholar
• ChattopadhyayS, PatraR, RamamurthyT, et al. Multiplex PCR assay for rapid detection and genotyping of H. pylori directly from biopsy specimens. J Clin Microbiol. 2004;42(6):2821–2824. doi:10.1128/JCM.42.6.2821-2824.200415184482
   PubMed Web of Science ®Google Scholar
• TaylorDE, GeZ, PurychD, et al. Cloning and sequence analysis of two copies of a 23S rRNA gene from H. pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Agents Chemother. 1997;41:477–480. doi:10.1128/AAC.41.12.2621
   Web of Science ®Google Scholar
• VeralsovicJ, OsatoMS, SpakovskyK, et al. Point mutations in the 23S rRNA gene of Helicobacter pylori-associated with different levels of clarithromycin resistance. J Antimicrob Chemother. 1997;40:283–286. doi:10.1093/jac/40.2.2839301997
   PubMed Web of Science ®Google Scholar
• HooiJKY, LaiWY, NgWK, et al. Global prevalence of H. pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153:420–429. doi:10.1053/j.gastro.2017.04.02228456631
   PubMed Web of Science ®Google Scholar
• MalfertheinerP, MegraudF, O’MorainCA, et al. Management of Helicobacter pylori infection-the maastricht IV/ florence consensus report. Gut. 2012;61:646–664. doi:10.1136/gutjnl-2012-30208422491499
   PubMed Web of Science ®Google Scholar
• GehlotVS, MahantaAK, MukhopadhyayKD, et al. Low level of clarithromycin-resistant H. pylori isolates with an A2143G point mutation in the 23S rRNA gene in North India. J Glob Antimicrob Resist. 2016;6:39–43. doi:10.1016/j.jgar.2016.02.00727530837
   PubMed Web of Science ®Google Scholar
• YakoobJ, JafriW, AbidS, et al. Role of rapid urease test and histopathology in the diagnosis of Helicobacter pylori infection in a developing country. BMC Gastroenterol. 2005;5:38. doi:10.1186/1471-230X-5-3816309551
   PubMed Web of Science ®Google Scholar
• YakoobJ, AbbasZ, KhanR, et al. Prevalence of non-Helicobacter pylori species in patients presenting with dyspepsia. BMC Gastroenterol. 2012;12:3. doi:10.1186/1471-230X-12-322226326
   PubMed Web of Science ®Google Scholar
• RasheedF, CampbellBJ, AlfizahH, et al. Analysis of clinical isolates of H. pylori in Pakistan reveals high degrees of pathogenicity and high frequencies of antibiotic resistance. Helicobacter. 2014;19:387–399. doi:10.1111/hel.1214224827414
   PubMed Web of Science ®Google Scholar
• TranVH, HaTMT, LePTQ, et al. Characterization of point mutations in domain V of 23S rRNA gene of clinical strains of H. pylori and clarithromycin-resistant phenotype in central Vietnam. J Glob Antimicrob Resist. 2018;16:87–91. doi:10.1016/j.jgar.2018.09.01230266639
   PubMed Web of Science ®Google Scholar
• NyiKN, SoeAM, HtutZM. Molecular detection of genotypic clarithromycin-resistant strains and its effect on the eradication rate of concomitant therapy in H. pylori infection. GastroHep. 2021;00: 1-7. doi:10.1002/ygh2.476
   Google Scholar
• KhasheiR, DaraM, BazarganiA, et al. The high rate of A2142G point mutation associated with clarithromycin resistance among Iranian H. pylori clinical isolates. APMIS. 2016;124(9):787–793. doi:10.1111/apm.1256727357065
   PubMed Web of Science ®Google Scholar
• Zhen-HuaZ, De-qiangH, YongX, et al. Characterization of 23S rRNA gene mutation in primary and secondary clarithromycin-resistant H. pylori strains from East China. Turk J Gastroenterol. 2013;24:5–9. doi:10.4318/tjg.2013.052523794337
   PubMed Web of Science ®Google Scholar
• Van-doornLJ, GlupczynskiY, KustersJG, et al. Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicentre validation study. Antimicrob Agents Chemother. 2001;45:1500–1504. doi:10.1128/AAC.45.5.1500-1504.200111302817
   PubMed Web of Science ®Google Scholar
• AlacornT, DomingoD, PrietoN, et al. PCR using 3ʹ-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates. J Clin Microbiol. 2000;38:923–925. doi:10.1128/JCM.38.2.923-925.200010655418
   PubMed Web of Science ®Google Scholar
• RimbaraE, NoguchiN, KijimaH, et al. Mutations in the 23S rRNA gene of clarithromycin-resistant Helicobacter pylori from Japan. Int J Antimicrob Agents. 2007;30:250–254. doi:10.1016/j.ijantimicag.2007.04.00917590317
   PubMed Web of Science ®Google Scholar
• AlfaresiMS, ElkoushAA. Characterization of clarithromycin resistance in isolates of Helicobacter pylori from the U. A. E. Indian J Gastroenterol. 2010;29:116–120. doi:10.1007/s12664-010-0034-z20658326
   PubMedGoogle Scholar
• LeeHK, ChaeHS, KangJO, et al. Multicentre study for the frequency of 23S rRNA point mutations associated with clarithromycin resistance in H. pylori in Korea. Korean J Clin Microbiol. 2008;11:12–15. doi:10.5145/KJCM.2008.11.2.84
   Google Scholar
• LeeHJ, KimJI, CheungDY, et al. Eradication of H. pylori according to 23S ribosomal RNA point mutations associated with clarithromycin resistance. J Infect Dis. 2013;208:1123–1130. doi:10.1093/infdis/jit28723801607
   PubMed Web of Science ®Google Scholar
• YakoobJ, JaffariW, AbbasZ, et al. Risk factors associated with H. pylori infection treatment failure in a high prevalence area. Epidemiol Infect. 2011;139:581–590. doi:10.1017/S095026881000122620525411
   PubMed Web of Science ®Google Scholar
• AhmadN, ZakariaWR, AbdullahSA, et al. Characterization of clarithromycin resistance in Malaysian isolates of Helicobacter pylori.. World J Gastroenterol. 2009;15:3161–3165. doi:10.3748/wjg.15.316119575497
   PubMed Web of Science ®Google Scholar
• WolleK, LeodolterA, MalfertheinerP, et al. Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000. J Med Microbiol. 2002;51:705–709. doi:10.1099/0022-1317-51-8-70512171304
   PubMed Web of Science ®Google Scholar
• FelloneCA. Epidemiology of the antibiotic resistance of Helicobacter pylori in Canada. Can J Gastroenterol. 2000;14:879–882. doi:10.1155/2000/56215911111111
   PubMed Web of Science ®Google Scholar
• LingTKW, LeungWK, LeeCC, et al. The antimicrobial susceptibility of Helicobacter pylori in Hong Kong (1997–2001). Helicobacter. 2002;7:327–329. doi:10.1046/j.1523-5378.2002.00101_1.x12390214
   PubMed Web of Science ®Google Scholar
• KimJJ, ReddyR, LeeM, et al. Analysis of metronidazole, clarithromycin, and tetracycline resistance of H. pylori isolates from Korea. J Antimicrob Chemother. 2001;47:459–461. doi:10.1093/jac/47.4.45911266421
   PubMed Web of Science ®Google Scholar
• LerangF, MoumB, HaugJB, et al. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?Am J Gastroenterol. 1997;92:248–253.9040200
   PubMed Web of Science ®Google Scholar
• LaineL, FennertyMB, OsatoM, et al. Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials. Am J Gastroenterol. 2000;95:3393–3398. doi:10.1111/j.1572-0241.2000.03349.x11151867
   PubMed Web of Science ®Google Scholar
• MohammediM, DoroudD, MassarratS, et al. Clarithromycin resistance in Iranian Helicobacter pylori strains before the introduction of clarithromycin. Helicobacter. 2003;8:79–80.12603620
   PubMed Web of Science ®Google Scholar
• KocazeybekB, TokmanHB. Prevalence of primary antimicrobial resistance of H. pylori in Turkey: a systematic review. Helicobacter. 2015. doi:10.1111/hel.12272
   Web of Science ®Google Scholar
• GhotaslouR, LeylabadloHE, AslYM. Prevalence of antibiotic resistance in H. pylori: a recent literature review. World J Methodol. 2015;5:164–174. doi:10.5662/wjm.v5.i3.16426413490
   PubMedGoogle Scholar
• KleinEY, VanBoeckelTP, MartinezEM, et al. Global increase, and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci. 2018;115(15):E3463–E3470. doi:10.1073/pnas.171729511529581252
   PubMed Web of Science ®Google Scholar
• GarridoL, ToledoH. Novel genotypes in Helicobacter pylori involving domain V of the 23S rRNA gene. Helicobacter. 2007;12(5):505–509. doi:10.1111/j.1523-5378.2007.00506.x17760718
   PubMed Web of Science ®Google Scholar
• SeoSI, DoBJ, KangJG, et al. Helicobacter pylori eradication according to sequencing-based 23S rRNA point mutation associated with clarithromycin resistance. J Clin Med. 2020;9:54. doi:10.3390/jcm9010054
   Web of Science ®Google Scholar
• KhanR, NaharS, SultanaJ, et al. T2182C mutation in 23S rRNA is associated with clarithromycin resistance in H. pylori isolates obtained in Bangladesh. Antimicrob Agents Chemother. 2004;48(9):3567–3569. doi:10.1128/AAC.48.9.3567-3569.200415328128
   PubMed Web of Science ®Google Scholar
• KimKS, KangJO, EunCS, et al. Mutations in the 23S rRNA gene of Helicobacter pylori-associated with clarithromycin resistance. J Korean Med Sci. 2002;17:599–603. doi:10.3346/jkms.2002.17.5.59912378008
   PubMed Web of Science ®Google Scholar
• GomezJE, Kaufmann-MalagaBB, WivaggCN, et al. Ribosomal mutations promote the evolution of antibiotic resistance in a multidrug environment. eLife. 2017;6:e20420. doi:10.7554/eLife.2042028220755
   PubMed Web of Science ®Google Scholar